Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

 PMID:33655249  

The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium.

Luke R Bonser | Walter L Eckalbar | Lauren Rodriguez | Jiangshan Shen | Kyung Duk Koh | Lorna T Zlock | Stephanie Christenson | Prescott G Woodruff | Walter E Finkbeiner | David J Erle
bioRxiv : the preprint server for biology | 2021

Asthma is associated with chronic changes in the airway epithelium, a key target of SARS-CoV-2. Many epithelial changes are driven by the type 2 cytokine IL-13, but the effects of IL-13 on SARS-CoV-2 infection are unknown.

Pubmed ID: 33655249

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK072517
  • Agency: NHLBI NIH HHS, United States
    Id: R00 HL135403
  • Agency: NHLBI NIH HHS, United States
    Id: R35 HL145235
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI077439

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Vero C1008 (tool)

RRID:CVCL_0574

Cell line Vero C1008 is a Spontaneously immortalized cell line with a species of origin Chlorocebus sabaeus

View all literature mentions